ATC 2016

Predicting Infections in Transplant Patients: Cellular Immune Assays for Tuberculosis and CMV

This program is intended for physicians, surgeons, scientists, nurses, organ procurement personnel, and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. It reviews the importance of screening for TB in transplant patients and explores the use of cellular immune assays to identify patients at risk of developing CMV post-transplant. Clinical case studies are presented to discuss the use of this information as part of a patient's overall clinical picture.
  • Presented by:
  • Roy F. Chemaly, MD, MPH, FIDSA, FACP
  • Camille Nelson Kotton, MD, FIDSA